Search research articles
Contact Us
Filters
Showing results (91-100 of 110) with videos related to
Page
of 11
Sort By:
Nature Medicine
|
August 8, 2006
Efomycine M: an inhibitor of selectins?
Arne von Bonin, Bernd Buchmann, Ben Bader, et al.
The British Journal of Dermatology
|
March 1, 1997
Leg ulcers in Klinefelter's syndrome--further evidence for an involvement of plasminogen activator inhibitor-1
T M Zollner, J C Veraart, M Wolter, et al.
The Journal of Investigative Dermatology
|
August 7, 2009
The role of mitogen-activated protein kinase-activated protein kinase 2 in the p38/TNF-alpha pathway of systemic and cutaneous inflammation
Arndt J Schottelius, Ulrich Zügel, Wolf-Dietrich Döcke, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 14, 1999
Overexpression of Bcl-2 in transgenic mice decreases apoptosis and improves survival in sepsis
R S Hotchkiss, P E Swanson, C M Knudson, et al.
Journal of Materials Chemistry. B
|
April 9, 2020
Polyglycerol-based amphiphilic dendrons as potential siRNA carriers for in vivo applications
Ariane Tschiche, Anna M Staedtler, Shashwat Malhotra, et al.
Physical Review Letters
|
September 10, 2016
Observation and Structure Determination of an Oxide Quasicrystal Approximant
S Förster, M Trautmann, S Roy, et al.
Journal of Medicinal Chemistry
|
February 2, 2019
Identification of a Benzimidazolecarboxylic Acid Derivative (BAY 1316957) as a Potent and Selective Human Prostaglandin E2 Receptor Subtype 4 (hEP4-R) Antagonist for the Treatment of Endometriosis
Stefan Bäurle, Jens Nagel, Olaf Peters, et al.
The Journal of Investigative Dermatology
|
November 22, 2005
Junctional adhesion molecules (JAM)-B and -C contribute to leukocyte extravasation to the skin and mediate cutaneous inflammation
Ralf J Ludwig, Thomas M Zollner, Sentot Santoso, et al.
Journal of Medicinal Chemistry
|
November 21, 2019
Discovery and Characterization of the Potent and Selective P2X4 Inhibitor <i>N</i>-[4-(3-Chlorophenoxy)-3-sulfamoylphenyl]-2-phenylacetamide (BAY-1797) and Structure-Guided Amelioration of Its CYP3A4 Induction Profile
Stefan Werner, Stefanie Mesch, Roman C Hillig, et al.
Scientific Reports
|
October 7, 2021
Eliapixant is a selective P2X3 receptor antagonist for the treatment of disorders associated with hypersensitive nerve fibers
Adam J Davenport, Ioana Neagoe, Nico Bräuer, et al.
Page
of 11
Search research articles
Search
Showing results (91-100 of 110) with videos related to
Sort By:
Page
of 11
Nature Medicine
|
August 8, 2006
Efomycine M: an inhibitor of selectins?
Arne von Bonin, Bernd Buchmann, Ben Bader, et al.
The British Journal of Dermatology
|
March 1, 1997
Leg ulcers in Klinefelter's syndrome--further evidence for an involvement of plasminogen activator inhibitor-1
T M Zollner, J C Veraart, M Wolter, et al.
The Journal of Investigative Dermatology
|
August 7, 2009
The role of mitogen-activated protein kinase-activated protein kinase 2 in the p38/TNF-alpha pathway of systemic and cutaneous inflammation
Arndt J Schottelius, Ulrich Zügel, Wolf-Dietrich Döcke, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
April 14, 1999
Overexpression of Bcl-2 in transgenic mice decreases apoptosis and improves survival in sepsis
R S Hotchkiss, P E Swanson, C M Knudson, et al.
Journal of Materials Chemistry. B
|
April 9, 2020
Polyglycerol-based amphiphilic dendrons as potential siRNA carriers for in vivo applications
Ariane Tschiche, Anna M Staedtler, Shashwat Malhotra, et al.
Physical Review Letters
|
September 10, 2016
Observation and Structure Determination of an Oxide Quasicrystal Approximant
S Förster, M Trautmann, S Roy, et al.
Journal of Medicinal Chemistry
|
February 2, 2019
Identification of a Benzimidazolecarboxylic Acid Derivative (BAY 1316957) as a Potent and Selective Human Prostaglandin E2 Receptor Subtype 4 (hEP4-R) Antagonist for the Treatment of Endometriosis
Stefan Bäurle, Jens Nagel, Olaf Peters, et al.
The Journal of Investigative Dermatology
|
November 22, 2005
Junctional adhesion molecules (JAM)-B and -C contribute to leukocyte extravasation to the skin and mediate cutaneous inflammation
Ralf J Ludwig, Thomas M Zollner, Sentot Santoso, et al.
Journal of Medicinal Chemistry
|
November 21, 2019
Discovery and Characterization of the Potent and Selective P2X4 Inhibitor <i>N</i>-[4-(3-Chlorophenoxy)-3-sulfamoylphenyl]-2-phenylacetamide (BAY-1797) and Structure-Guided Amelioration of Its CYP3A4 Induction Profile
Stefan Werner, Stefanie Mesch, Roman C Hillig, et al.
Scientific Reports
|
October 7, 2021
Eliapixant is a selective P2X3 receptor antagonist for the treatment of disorders associated with hypersensitive nerve fibers
Adam J Davenport, Ioana Neagoe, Nico Bräuer, et al.
Page
of 11